Durham, NC, United States of America

Jiangbo Wang

This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Duke University. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiangbo Wang. Retrieved from https://idiyas.com/inventor/jiangbo-wang-unov0n6i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jiangbo Wang: Innovator in Therapeutic Compounds

Introduction

Jiangbo Wang is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of therapeutic compounds, holding a total of 5 patents. His work focuses on addressing diseases associated with dysregulation of critical signaling pathways.

Latest Patents

Wang's latest patents include innovative compounds and methods for treating various diseases. One notable patent is for "Niclosamide analogues and therapeutic use thereof." This patent describes niclosamide analogue compounds and their pharmaceutical compositions, which are used to treat diseases linked to the Wnt/Frizzled signaling pathway, including cancer, fatty liver, antibiotic resistance, and viral infections. Additionally, these compounds may modulate mitochondrial function and treat non-cancer diseases such as diabetes and fibrotic diseases.

Another significant patent is titled "Chemical modulators of signaling pathways and therapeutic use." This patent outlines methods for treating diseases related to the Wnt/Frizzled signaling pathway. The methods involve identifying subjects in need of therapy and administering inhibitors of this pathway, which can be used to treat conditions such as cancer, bacterial and viral infections, lupus, and type II diabetes.

Career Highlights

Jiangbo Wang is affiliated with Duke University, where he conducts his research and development in therapeutic innovations. His work has garnered attention for its potential impact on treating complex diseases.

Collaborations

Wang collaborates with esteemed colleagues, including Wei Chen and Herbert K. Lyerly, to advance research in his field. Their combined expertise enhances the potential for groundbreaking discoveries.

Conclusion

Jiangbo Wang's contributions to the field of therapeutic compounds demonstrate his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of complex biological pathways and their implications for disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…